Related Experiment Video

Updated: Jun 10, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

809

The Bidirectional Association Between Metabolic Syndrome and Long-COVID-19

Yanfen Liu1, Xueyong Lou1

  • 1Department of Endocrinology at Zhejiang University School of Medicine, Jinhua Hospital, Jinhua, People's Republic of China.

Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|October 14, 2024
PubMed

Insights

Long COVID and metabolic syndrome significantly impact health, increasing risks for heart and brain diseases. This review systematically examines their interaction, treatment, and prognosis.

Area of Science:

  • Infectious Diseases
  • Metabolic Disorders
  • Public Health

Background:

  • The COVID-19 pandemic has led to increased mortality and long-term health consequences.
  • Long COVID, a post-viral syndrome, affects individual health and well-being.
  • Metabolic syndrome poses significant risks for cardiovascular and cerebrovascular diseases.

Purpose of the Study:

  • To systematically review the interaction between long COVID prognosis and metabolic syndrome progression.
  • To explore the pathogenesis of both conditions.
  • To summarize current treatment strategies and prognostic factors.

Main Methods:

  • Systematic literature review.
  • Analysis of existing research on long COVID and metabolic syndrome.
  • Synthesis of data on pathogenesis, treatment, and prognosis.

Main Results:

  • The interaction between long COVID and metabolic syndrome is complex and warrants further investigation.
  • Specific mechanisms linking viral infection to metabolic dysfunction are being elucidated.
  • Evidence suggests potential therapeutic targets for managing both conditions.

Conclusions:

  • Understanding the interplay between long COVID and metabolic syndrome is crucial for patient outcomes.
  • Further research is needed to develop targeted interventions.
  • This review highlights the need for a comprehensive approach to managing patients with co-occurring conditions.
Abstract

Keywords:
Cardiovascular diseaseLong COVIDMetabolic syndromedrugspathway

More Related Videos

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

22.4K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.7K

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.1K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
24
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
25
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
388
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K